ASCRS Focus on Cataract Surgery
Light Adjustable Lens
June 2022 update
As technology continues to evolve, today's refractive cataract surgeon must stay up to date on new IOL technologies as they enter the market. One such advancement is the light adjustable lens, which began its commercial launch in the United States in September 2019 and has continued to expand in usage due to its refractive benefits. This lens can be adjusted postoperatively in order to optimize refractive outcomes for difficult cases.
In this updated ASCRS Focus on Cataract Surgery, explore a curated library of the latest educational resources on the light adjustable IOL.
Featured Light-Adjustable Lens Presentations
Early experience with the LAL - how to incorporate the technology
Presented by Nicole Fram, MD
In this presentation from the 2022 Winter Symposium, Nicole Fram, MD, covers basics on the light-adjustable lens and why the light-adjustable lens may be a benefit to your practice.
The future is here with the light adjustable lens, which
allows for postoperative power adjustments as much as +/- 2D sphere and +/- 2D
Kevin M. Miller, MD
The Light Adjustable Lens (LAL, RxSight) offers the unique opportunity to lock in the preferred vision after surgery. With recent updates, the technology can be an attractive option for a variety of refractive cataract patients. Several surgeons discussed how they use this IOL in their practice....
Read more on EyeWorld.org >>
Though FDA approved, the Light Adjustable Lens (LAL, RxSight, Aliso Viejo, California) is not yet currently available in the U.S. Robert Maloney, MD, Los Angeles, John Doane, MD, Leawood, Kansas, David F. Chang, MD, Los Altos, California, and Kevin Waltz, MD, Indianapolis, discussed their experience with the lens in clinical trial, how it works, and for what corrections it has approval....
Read more on EyeWorld.org >>
Presentations On Demand
Enjoy this selection of presentations from previous ASCRS Annual Meetings.
Long-term follow-up and clinical evaluation of the light-adjustable intraocular lens implanted after cataract removal: 7-year results
Journal of Cataract & Refractive Surgery: January 2020 - Volume 46 - Issue 1
Authors: Schojai, Merita MD; Schultz, Tim MD; Schulze, Katrin MD; Hengerer, Fritz H. MD, PhD; Dick, H. Burkhard MD, PhD
The purpose of this study is to determine the long-term safety and effectiveness of a light-adjustable intraocular lens (LAL) over a period that is longer than reported in the literature at the time of the study.
Featured Scientific Paper Presentation
Visual Outcomes of Patients Bilaterally Implanted with the Light Adjustable Lens
Captured at the 2022 ASCRS Annual MeetingSession: SPS-208 Cataract IOLs- Monofocal/Extended Depth of Focus
Presenting Author: Kerry D. Solomon, MD
Authors: Richard J Potvin, OD, Helga P. Sandoval, MD, MSc
The purpose of this paper is to evaluate visual outcomes after implantation and light treatment of a light adjustable lens (LAL) in patients after routine cataract surgery.
View Paper Presentation